102120-96-7

Basic information

• Product Name: 2-Thiopheneethanamine, N-(1,2,3,4-tetrahydro-5-methoxy-2-naphthalenyl)-, hydrochloride
• Synonyms: 2-Thiopheneethanamine, N-(1,2,3,4-tetrahydro-5-methoxy-2-naphthalenyl)-, hydrochloride;rac-N-(1,2,3,4-Tetrahydro-5-methoxy-2-naphthalenyl)-2-thiopheneethanamine Hydrochloride;5-Methoxy-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride
• CAS NO: 102120-96-7
• Molecular Formula: C17H22ClNOS
• Molecular Weight: 323.89
• Product Categories: Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds
• Mol File: 102120-96-7.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 473.7°C at 760 mmHg
• Flash Point: 240.3°C
• Appearance: /
• Vapor Pressure: 2.27E-09mmHg at 25°C
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: DMSO
• CAS DataBase Reference: 2-Thiopheneethanamine, N-(1,2,3,4-tetrahydro-5-methoxy-2-naphthalenyl)-, hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Thiopheneethanamine, N-(1,2,3,4-tetrahydro-5-methoxy-2-naphthalenyl)-, hydrochloride(102120-96-7)
• EPA Substance Registry System: 2-Thiopheneethanamine, N-(1,2,3,4-tetrahydro-5-methoxy-2-naphthalenyl)-, hydrochloride(102120-96-7)

Safety Data

• Hazardous Substances Data: 102120-96-7(Hazardous Substances Data)

Usage

Chemical Properties

Light Purple Solid

Uses

Intermediate in the production of Rotigotin

InChI:InChI=1/C17H21NOS.ClH/c1-19-17-6-2-4-13-12-14(7-8-16(13)17)18-10-9-15-5-3-11-20-15;/h2-6,11,14,18H,7-10,12H2,1H3;1H

Upstream product

• 32940-15-1 5-methoxy-2-tetralone 

Downstream Products

• 129672-61-3 2-[N-2-(2-Thienyl)ethylamino]-5-hydroxytetralin 

Relevant articles and documents

Method for detecting dopaminergic diseases using fluorine-18 radiolabelled D2 dopamine receptor ligands

Abnormalitites in the distribution of a dopamine D 2 receptors in humans and other mammals are detected by(1) administering to a human or other mammal an amount of a 18 F-radiolabelled compound sufficient to be detected by a positron emission sensitive means for imaging, said compound having affinity for said receptors selected from the group consisting of optically active or racemic compounds represented by the general formula: STR1 (2) forming at least one image showing the distribution of the radiolabelled compound within the human or other mammal using a positron emission-sensitive means for imaging; and(3) determining normality of the concentrations or distribution by comparing the image with an image showing the normal concentrations and distribution of the receptors in humans or mammals of the same species wherein R1-R4, n and m- are as set forth in the specification.